- Home
- BRKR vs PATH Comparison
BRKR vs PATH Comparison
Compare BRKR & PATH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BRKR | PATH |
|---|---|---|
| Founded | 1960 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Computer Software: Prepackaged Software |
| Sector | Industrials | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.7B | 5.6B |
| IPO Year | 2000 | 2021 |
Fundamental Metrics
Financial Performance| Metric | BRKR | PATH |
|---|---|---|
| Price | $59.71 | $10.69 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 13 | 17 |
| Target Price | ★ $48.54 | $14.41 |
| AVG Volume (30 Days) | 2.6M | ★ 49.1M |
| Earning Date | 05-06-2026 | 05-28-2026 |
| Dividend Yield | ★ 0.58% | N/A |
| EPS Growth | N/A | ★ 500.00 |
| EPS | 0.02 | ★ 0.04 |
| Revenue | ★ $1,895,600,000.00 | $1,610,572,000.00 |
| Revenue This Year | $6.30 | $11.82 |
| Revenue Next Year | $3.81 | $8.50 |
| P/E Ratio | $3,045.50 | ★ $263.25 |
| Revenue Growth | N/A | ★ 12.65 |
| 52 Week Low | $28.53 | $9.20 |
| 52 Week High | $64.54 | $19.84 |
Technical Indicators
Market Signals| Indicator | BRKR | PATH |
|---|---|---|
| Relative Strength Index (RSI) | 61.04 | 51.07 |
| Support Level | $46.84 | $10.61 |
| Resistance Level | $64.54 | $11.26 |
| Average True Range (ATR) | 2.45 | 0.54 |
| MACD | -0.15 | -0.03 |
| Stochastic Oscillator | 66.53 | 63.93 |
Price Performance
Historical ComparisonAbout BRKR Bruker Corporation
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies (BEST) . The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.
About PATH UiPath Inc.
UiPath Inc offers an end-to-end cross-application enterprise automation platform principally with computer vision technology and user interface automations in its initial RPA offering, which remains the foundation of the platform. The platform leverages a range of automation technologies, including robotic process automation, application programming interface, and artificial intelligence. UiPath's solution can automate a broad range of repetitive tasks across industries, including claims processing, employee onboarding, invoice-to-cash, loan applications, and customer service. The company works in the Americas, Europe, the Middle East, and Africa, and Asia-Pacific, with the maximum revenue from the America.